Spinal high-mobility group box-1 induces long-lasting mechanical hypersensitivity through the toll-like receptor 4 and upregulation of interleukin-1β in activated astrocytes.
HMGB1
TLR4
allodynia
glutamate
interleukin-1β
neuropathic pain
Journal
Journal of neurochemistry
ISSN: 1471-4159
Titre abrégé: J Neurochem
Pays: England
ID NLM: 2985190R
Informations de publication
Date de publication:
09 2019
09 2019
Historique:
received:
01
02
2019
revised:
19
06
2019
accepted:
26
06
2019
pubmed:
6
7
2019
medline:
24
3
2020
entrez:
6
7
2019
Statut:
ppublish
Résumé
Intrathecal treatment with recombinant high-mobility group box-1 (rHMGB1) in naïve mice leads to a persistent and significantly decreased hind paw withdrawal threshold to mechanical stimuli, suggesting that spinal HMGB1 evokes abnormal pain processing. By contrast, repeated intrathecal treatment with anti-HMGB1 antibody significantly reverses hind paw mechano-hypersensitivity in mice with a partial sciatic nerve ligation (PSNL). By contrast, the cellular mechanism by which spinal HMGB1 induces neuropathic pain has yet to be fully elaborated. The current study tested the hypothesis that spinal HMGB1 could induce mechanical hypersensitivity through the activation of specific receptor in glial cells. Intrathecal pretreatment with toll-like receptor (TLR) 4 inhibitors, but not TLR5, receptor for advanced glycation end-products and C-X-C chemokine receptor type 4 inhibitors, prevented rHMGB1-evoked mechanical hypersensitivity. Activation of spinal astrocytes appears to be crucial for the mechanism of action of rHMGB1 in naïve mice, as intrathecal pretreatment with astrocytic inhibitors prevented the rHMGB1-induced mechanical hypersensitivity. Interleukin-1β (IL-1β) was up-regulated within activated astrocytes and block of TLR4 prevented the upregulation of IL-1β. Interleukin-1β appears to be secreted by activated astrocytes, as IL-1β neutralizing antibody prevented rHMGB1-induced mechanical hypersensitivity. Furthermore, intrathecal pretreatment with either MK801 or gabapentin prevented the rHMGB1-induced mechanical hypersensitivity, suggesting roles for spinal glutamate and the N-methyl-d-aspartate receptor in the mediation of rHMGB1-induced mechanical hypersensitivity. Thus, the current findings suggest that spinal HMGB1 upregulates IL-1β in spinal astrocytes through a TLR4-dependent pathway and increases glutamatergic nociceptive transduction. These spinal mechanisms could be key steps that maintain neuropathic pain.
Substances chimiques
HMGB1 Protein
0
HMGB1 protein, mouse
0
IL1B protein, mouse
0
Interleukin-1beta
0
Tlr4 protein, mouse
0
Toll-Like Receptor 4
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
738-758Informations de copyright
© 2019 International Society for Neurochemistry.
Références
Agalave N. M. and Svensson C. I. (2015) Extracellular high-mobility group box 1 protein (HMGB1) as a mediator of persistent pain. Mol. Med. 20, 569-578.
Agalave N. M., Larsson M., Abdelmoaty S., et al. (2014) Spinal HMGB1 induces TLR4-mediated long-lasting hypersensitivity and glial activation and regulates pain-like behavior in experimental arthritis. Pain 155, 1802-1813.
Allette Y. M., Due M. R., Wilson S. M., Feldman P., Ripsch M. S., Khanna R. and White F. A. (2014) Identification of a functional interaction of HMGB1 with receptor for advanced glycation end-products in a model of neuropathic pain. Brain Behav. Immun. 42, 169-177.
An K., Rong H., Ni H., et al. (2018) Spinal PKC activation - induced neuronal HMGB1 translocation contributes to hyperalgesia in a bone cancer pain model in rats. Exp. Neurol. 303, 80-94.
Andersson U. and Tracey K. J. (2011) HMGB1 is a therapeutic target for sterile inflammation and infection. Annu. Rev. Immunol. 29, 139-162.
Andersson U., Erlandsson-Harris H., Yang H. and Tracey K. J. (2002) HMGB1 as a DNA-binding cytokine. J. Leukoc. Biol. 72, 1084-1091.
Bettoni I., Comelli F., Rossini C., Granucci F., Giagnoni G., Peri F. and Costa B. (2008) Glial TLR4 receptor as new target to treat neuropathic pain: efficacy of a new receptor antagonist in a model of peripheral nerve injury in mice. Glia 56, 1312-1319.
Brederson J. D., Strakhova M., Mills C., et al. (2016) A monoclonal antibody against the receptor for advanced glycation end products attenuates inflammatory and neuropathic pain in the mouse. Eur. J. Pain 20, 607-614.
Cheng J. K. and Chiou L. C. (2006) Mechanisms of the antinociceptive action of gabapentin. J. Pharmacol. Sci. 100, 471-486.
Das N., Dewan V., Grace P. M., Gunn R. J., Tamura R., Tzarum N., Watkins L. R., Wilson I. A. and Yin H. (2016) HMGB1 Activates proinflammatory signaling via TLR5 leading to allodynia. Cell Rep. 17, 1128-1140.
Fang P., Schachner M. and Shen Y. Q. (2012) HMGB1 in development and diseases of the central nervous system. Mol. Neurobiol. 45, 499-506.
Frank M. G., Weber M. D., Fonken L. K., Hershman S. A., Watkins L. R. and Maier S. F. (2016) The redox state of the alarmin HMGB1 is a pivotal factor in neuroinflammatory and microglial priming: a role for the NLRP3 inflammasome. Brain. Behav. Immun. 55, 215-224.
Grace P. M., Hutchinson M. R., Maier S. F. and Watkins L. R. (2014) Pathological pain and the neuroimmune interface. Nat. Rev. Immunol. 14, 217-231.
Gruber-Schoffnegger D., Drdla-Schutting R., Hönigsperger C., Wunderbaldinger G., Gassner M. and Sandkühler J. (2013) Induction of thermal hyperalgesia and synaptic long-term potentiation in the spinal cord lamina I by TNF-α and IL-1β is mediated by glial cells. J. Neurosci. 33, 6540-6551.
Hylden J. L. and Wilcox G. L. (1980) Intrathecal morphine in mice: a new technique. Eur. J. Pharmacol. 67, 313-316.
Izushi Y., Teshigawara K., Liu K., et al. (2016) Soluble form of the receptor for advanced glycation end-products attenuates inflammatory pathogenesis in a rat model of lipopolysaccharide-induced lung injury. J. Pharmacol. Sci. 130, 226-234.
Ji R. R., Kawasaki Y., Zhuang Z. Y., Wen Y. R. and Decosterd I. (2006) Possible role of spinal astrocytes in maintaining chronic pain sensitization: review of current evidence with focus on bFGF/JNK pathway. Neuron Glia Biol. 2, 259-269.
Ji R. R., Chamessian A. and Zhang Y. Q. (2016) Pain regulation by non-neuronal cells and inflammation. Science 354, 572-577.
Kawasaki Y., Zhang L., Cheng J. K. and Ji R. R. (2008) Cytokine mechanisms of central sensitization: distinct and overlapping role of interleukin-1beta, interleukin-6, and tumor necrosis factor-alpha in regulating synaptic and neuronal activity in the superficial spinal cord. J. Neurosci. 28, 5189-5194.
Liu K., Mori S., Takahashi H. K., et al. (2007) Anti-high mobility group box 1 monoclonal antibody ameliorates brain infarction induced by transient ischemia in rats. FASEB J. 21, 3904-3916.
Liu B., Su M., Tang S., Zhou X., Zhan H., Yang F., Li W., Li T. and Xie J. (2016) Spinal astrocytic activation contributes to mechanical allodynia in a rat model of cyclophosphamide-induced cystitis. Mol. Pain 12,1-12.
Luo X., Tai W. L., Sun L., Qiu Q., Xia Z., Chung S. K. and Cheung C. W. (2014) Central administration of C-X-C chemokine receptor type 4 antagonist alleviates the development and maintenance of peripheral neuropathic pain in mice. PLoS ONE 9, e104860.
Luo X., Tai W. L., Sun L., Pan Z., Xia Z., Chung S. K. and Cheung C. W. (2016) Crosstalk between astrocytic CXCL12 and microglial CXCR22 contributes to the development of neuropathic pain. Mol Pain 12,1-15.
Maeda T., Ozaki M., Kobayashi Y., Kiguchi N. and Kishioka S. (2013) HMGB1 as a potential therapeutic target for neuropathic pain. J. Pharmacol. Sci. 123, 301-305.
Mika J., Zychowska M., Popiolek-Barczyk K., Rojewska E. and Przewlocka B. (2013) Importance of glial activation in neuropathic pain. Eur. J. Pharmacol. 716, 106-119.
Moalem G. and Tracey D. J. (2006) Immune and inflammatory mechanisms in neuropathic pain. Brain Res. Rev. 51, 240-264.
Morioka N., Sugimoto T., Tokuhara M., Nakamura Y., Abe H., Hisaoka K., Dohi T. and Nakata Y. (2012) Spinal astrocytes contribute to the circadian oscillation of glutamine synthase, cyclooxygenase-1 and clock genes in the lumbar spinal cord of mice. Neurochem. Int. 60, 817-826.
Morioka N., Zhang F. F., Nakamura Y., Kitamura T., Hisaoka-Nakashima K. and Nakata Y. (2015) Tumor necrosis factor-mediated downregulation of spinal astrocytic connexin43 leads to increased glutamatergic neurotransmission and neuropathic pain in mice. Brain Behav. Immun. 49, 293-310.
Morioka N., Saeki M., Sugimoto T., Higuchi T., Zhang F. F., Nakamura Y., Hisaoka-Nakashima K. and Nakata Y. (2016) Downregulation of the spinal dorsal horn clock gene Per1 expression leads to mechanical hypersensitivity via c-jun N-terminal kinase and CCL2 production in mice. Mol. Cell. Neurosci. 72, 72-83.
Morioka N., Kodama K., Tomori M., Yoshikawa K., Saeki M., Nakamura Y., Zhang F. F., Hisaoka-Nakashima K. and Nakata Y. (2019) Stimulation of nuclear receptor REV-ERBs suppresses production of pronociceptive molecules in cultured spinal astrocytes and ameliorates mechanical hypersensitivity of inflammatory and neuropathic pain of mice. Brain Behav. Immun. 78, 116-130.
Muth I. E., Zschüntzsch J., Kleinschnitz K., et al. (2015) HMGB1 and RAGE in skeletal muscle inflammation: implications for protein accumulation in inclusion body myositis. Exp. Neurol. 271, 189-197.
Nakagawa T. and Kaneko S. (2010) Spinal astrocytes as therapeutic targets for pathological pain. J. Pharmacol. Sci. 114, 347-353.
Nakamura Y., Morioka N., Abe H., Zhang F. F., Hisaoka-Nakashima K., Liu K., Nishibori M. and Nakata Y. (2013) Neuropathic pain in rats with a partial sciatic nerve ligation is alleviated by intravenous injection of monoclonal antibody to high mobility group box-1. PLoS ONE 8, e73640.
Nakamura Y., Morioka N., Zhang F. F., Hisaoka-Nakashima K. and Nakata Y. (2015) Downregulation of connexin36 in mouse spinal dorsal horn neurons leads to mechanical allodynia. J. Neurosci. Res. 93, 584-591.
Nakano Y., Shimazawa M., Ojino K., Izawa H., Takeuchi H., Inoue Y., Tsuruma K. and Hara H. (2017) Toll-like receptor 4 inhibitor protects against retinal ganglion cell damage induced by optic nerve crush in mice. J. Pharmacol. Sci. 133, 176-183.
Pedrazzi M., Averna M., Sparatore B., et al. (2012) Potentiation of NMDA receptor-dependent cell responses by extracellular high mobility group box 1 protein. PLoS ONE 7, e44518.
Peirs C. and Seal R. P. (2016) Neural circuits for pain: recent advances and current views. Science 354, 578-584.
Ren P. C., Zhang Y., Zhang X. D., An L. J., Lv H. G., He J., Gao C. J. and Sun X. D. (2012) High-mobility group box 1 contributes to mechanical allodynia and spinal astrocytic activation in a mouse model of type 2 diabetes. Brain Res. Bull. 88, 332-337.
Sakamoto K., Mizuta A., Fujimura K., Kurauchi Y., Mori A., Nakahara T. and Ishii K. (2015) High-mobility group Box-1 is involved in NMDA-induced retinal injury the in rat retina. Exp. Eye Res. 137, 63-70.
Sasaki T., Liu K., Agari T., et al. (2016) Anti-high mobility group box 1 antibody exerts neuroprotection in a rat model of Parkinson's disease. Exp. Neurol. 275(Pt 1), 220-231.
Shibasaki M., Sasaki M., Miura M., Mizukoshi K., Ueno H., Hashimoto S., Tanaka Y. and Amaya F. (2010) Induction of high mobility group box-1 in dorsal root ganglion contributes to pain hypersensitivity after peripheral nerve injury. Pain 149, 514-521.
Stojanovic I., Cuzzocrea S., Mangano K., et al. (2007) In vitro, ex vivo and in vivo immunopharmacological activities of the isoxazoline compound VGX-1027: modulation of cytokine synthesis and prevention of both organ-specific and systemic autoimmune diseases in murine models. Clin. Immunol. 123, 311-323.
Sung C. S., Wen Z. H., Feng C. W., Chen C. H., Huang S. Y., Chen N. F., Chen W. F. and Wong C. S. (2017) Potentiation of spinal glutamatergic response in the neuron-glia interactions underlies the intrathecal IL-1β-induced thermal hyperalgesia in rats. CNS Neurosci. Ther. 23, 580-589.
Tong W., Wang W., Huang J., Ren N., Wu S. X. and Li Y. Q. (2010) Spinal high-mobility group box 1 contributes to mechanical allodynia in a rat model of bone cancer pain. Biochem. Biophys. Res. Commun. 395, 572-576.
Tsuda M., Koga K., Chen T. and Zhuo M. (2017) Neuronal and microglial mechanisms for neuropathic pain in the spinal dorsal horn and anterior cingulate cortex. J. Neurochem. 141, 486-498.
Wang Y. S., Li Y. Y., Cui W., Li L. B., Zhang Z. C., Tian B. P. and Zhang G. S. (2017) Melatonin attenuates pain hypersensitivity and decreases astrocyte-mediated spinal neuroinflammation in a rat model of oxaliplatin-induced pain. Inflammation 40, 2052-2061.
Woller S. A., Ravula S. B., Tucci F. C., et al. (2016) Systemic TAK-242 prevents intrathecal LPS evoked hyperalgesia in male, but not female mice and prevents delayed allodynia following intraplantar formalin in both male and female mice: the role of TLR4 in the evolution of a persistent pain state. Brain Behav. Immun. 56, 271-280.
Yan X. and Weng H. R. (2013) Endogenous interleukin-1β in neuropathic rats enhances glutamate release from the primary afferents in the spinal dorsal horn through coupling with presynaptic N-methyl-d-aspartic acid receptors. J. Biol. Chem. 288, 30544-30557.
Yan W., Chang Y., Liang X., et al. (2012) High-mobility group box 1 activates caspase-1 and promotes hepatocellular carcinoma invasiveness and metastases. Hepatology 55, 1863-1875.
Zhang J., Takahashi H. K., Liu K., et al. (2011) Anti-high mobility group box-1 monoclonal antibody protects the blood-brain barrier from ischemia-induced disruption in rats. Stroke 42, 1420-1428.
Zhang F. F., Morioka N., Harano S., Nakamura Y., Liu K., Nishibori M., Hisaoka-Nakashima K. and Nakata Y. (2015a) Perineural expression of high-mobility group box-1 contributes to long-lasting mechanical hypersensitivity via matrix metalloproteinase-9 upregulation in mice with painful peripheral neuropathy. J Neurochem. 136, 837-850.
Zhang Y., Zhu T., Zhang X., Chao J., Hu G. and Yao H. (2015b) Role of high-mobility group box 1 in methamphetamine-induced activation and migration of astrocytes. J. Neuroinflammation 12, 156.
Zhao X. H., Zhang T. and Li Y. Q. (2015) The up-regulation of spinal Toll-like receptor 4 in rats with inflammatory pain induced by complete Freund's adjuvant. Brain Res. Bull. 111, 97-103.